Spire Washington Hospital invests £1.3m improving operating theatres benefiting NHS and private patients

18 June 2024

  • Investment is provided to upgrade and modernise operating theatres
  • Ensuring high standards of safety and healthcare for both NHS and private patients

Spire Healthcare CEO Justin Ash has unveiled the £1.3 million newly upgraded operating theatres at Spire Washington Hospital. The investment into the new theatre suite provides a modernised innovative design to support safety, infection prevention and ensuring highest standards of healthcare for both patients and colleagues.

The refurbishment began in February 2024 and is now open following eight weeks of reduced patient capacity. During the refurbishment the Spire Washington team worked tirelessly to create minimal disruptions for patients and to ensure continuous delivery of high-quality patient care.  

Theatre refurbishment at Spire Washington Hospital

Andrew Johnson, Hospital Director at Spire Washington Hospital, said: “At Spire Washington Hospital, we offer fast access to expert care with leading specialists, in a hospital where safety comes first. This significant investment in our theatre suite, will benefit patients and colleagues, and help us maintain the high standards in healthcare that patients have come to expect from Spire hospitals.”

Richard Smith, Director of Clinical Services at Spire Washington Hospital, said: “Advancements in healthcare continue at an amazing rate so it is important that we keep pace with those developments. The upgraded facilities at Spire Washington particularly in our Theatre Complex and Outpatient Department will be welcomed by our consultants and colleagues and patients alike within the hospital and underlines Spire Healthcare’s confidence and commitment to expanding and improving hospital facilities.”

Spire Healthcare CEO Justin Ash unveils £1.3 million newly upgraded operating theatres

Event Booking Form

145490

Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

We will use your personal information to process your enquiry. For further information, please see our privacy policy.

Submit my enquiry